Nano X Imaging Ltd
$ 1.06
3.92%
07 Aug - close price
- Market Cap 73,777,000 USD
- Current Price $ 1.06
- High / Low $ 1.07 / 1.01
- Stock P/E N/A
- Book Value 2.01
- EPS -1.15
- Next Earning Report 2026-08-11
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.22 %
- ROE -0.50 %
- 52 Week High 4.88
- 52 Week Low 0.73
About
Nano-X Imaging Ltd., a development-stage company, develops, produces and markets digital X-ray source technology for the medical imaging industry globally. The company is headquartered in Neve Ilan, Israel.
Analyst Target Price
$5.13
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-20 | 2025-12-31 | 2025-11-20 | 2025-08-12 | 2025-05-22 | 2025-03-31 | 2024-11-21 | 2024-08-20 | 2024-05-28 | 2024-03-14 | 2023-11-28 | 2023-08-17 |
| Reported EPS | -0.2 | -0.17 | -0.15 | -0.17 | -0.15 | -0.17 | -0.15 | -0.14 | -0.21 | -0.18 | -0.37 | -0.31 |
| Estimated EPS | -0.14 | -0.15 | -0.17 | -0.15 | -0.15 | -0.15 | -0.15 | -0.15 | -0.26 | -0.3 | -0.3 | -0.26 |
| Surprise | -0.06 | -0.02 | 0.02 | -0.02 | 0 | -0.02 | 0 | 0.01 | 0.05 | 0.12 | -0.07 | -0.05 |
| Surprise Percentage | -42.8571% | -13.3333% | 11.7647% | -13.3333% | 0% | -13.3333% | 0% | 6.6667% | 19.2308% | 40% | -23.3333% | -19.2308% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-11 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NNOX
2026-08-07 21:39:41
Nano-X Imaging Ltd. (NNOX) has completed an $8.0 million registered direct offering with a single institutional investor. The offering included 8,000,000 ordinary shares (or pre-funded warrants) and 8,000,000 ordinary warrants, with proceeds intended for working capital and general corporate purposes. A.G.P./Alliance Global Partners served as the sole placement agent, receiving a 5.0% cash fee.
2026-08-07 00:10:44
Nano-X Imaging Ltd. (NASDAQ: NNOX) has secured an $8 million registered direct offering with a long-term institutional investor. The financing, involving the sale of 8 million ordinary shares or prefunded warrants and accompanying warrants, aims to provide working capital and support the company's corporate initiatives. This capital raise will help Nano-X advance its integrated healthcare platform, which includes imaging hardware, AI-based solutions, and cloud services, to expand access to preventive medical imaging.
2026-08-06 19:59:00
Pomerantz LLP has filed a class action lawsuit against Nano-X Imaging Ltd. (NASDAQ: NNOX) and certain officers, alleging materially false and misleading statements were made to investors between March 31, 2025, and April 17, 2026. The lawsuit claims Nano-X overstated efficiency gains and demand, leading to increased operating expenses and cash burn, which was later revealed by significant impairment charges and a leadership change. Investors who purchased Nano-X securities during this period have until August 11, 2026, to seek appointment as Lead Plaintiff.
2026-08-06 18:04:59
Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Nano-X Imaging Ltd. (NASDAQ:NNOX) and its officers. The lawsuit alleges that Nano-X made materially false and misleading statements about its business, operations, and prospects, specifically overstating efficiency and demand while experiencing increased operating expenses and cash burn. Shareholders who purchased Nano-X securities between March 31, 2025, and April 17, 2026, have until August 11, 2026, to request to be appointed lead plaintiff.
2026-08-06 16:10:44
A class action lawsuit has been filed against Nano-X Imaging Ltd. (NASDAQ: NNOX) and its officers, alleging violations of federal securities laws. The lawsuit claims that Nano-X made materially false and misleading statements regarding its operations, overstating efficiency gains and demand, while facing increased operating expenses and cash burn due to poor alignment between production and demand. Investors who purchased Nano-X securities between March 31, 2025, and April 17, 2026, are encouraged to join the case and have until August 11, 2026, to request lead plaintiff appointment.
2026-08-06 14:10:44
Nano-X Imaging Ltd. (NASDAQ:NNOX) has secured $8 million through a registered direct offering with a single institutional investor. The offering involved the sale of 8,000,000 ordinary shares and warrants to purchase an equal number of additional shares, priced at $1.00 per combined share and warrant. The net proceeds will be allocated towards working capital and general corporate purposes for the medical imaging technology company.
